Medicinova Inc (MNOV): who owns it and who trades it
As of Nov 16, 2026, MNOV insiders reported 1 open-market sale worth $1.7M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was 3D Opportunity Master Fund (Other), with $1.7M. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Medicinova
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Insider trades
In the last 12 months, MNOV insiders reported $0 of open-market purchases and $1.7M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | 3D Opportunity Master Fund +1 | Other | Sale | 640,000 | $2.70 | $1.7M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| 3D Opportunity Master Fund | Other | – | $1.7M | Sep 25, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
MNOV short interest
Low short interest. 0.6% of MNOV shares are sold short: about 1 share in 173. Over the last 12 reports the number of shares short went up 86%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 285,184 MNOV shares were sold short, 0.6% of the shares outstanding, down 2.4% from the report before. At the average daily volume of 52,467 shares, buying them all back would take about 5.4 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 285,184 | 0.58% | -2% | 52,467 | 5.4 |
| Oct 15, 2026 | 292,306 | 0.59% | -14% | 130,749 | 2.2 |
| Sep 30, 2026 | 339,114 | 0.69% | -9% | 1.56M | 1.0 |
| Sep 15, 2026 | 374,674 | 0.76% | +1% | 87,724 | 4.3 |
| Aug 31, 2026 | 369,685 | 0.75% | +12% | 47,991 | 7.7 |
| Aug 14, 2026 | 331,436 | 0.67% | -4% | 28,128 | 11.8 |
| Jul 31, 2026 | 346,440 | 0.70% | +12% | 39,587 | 8.8 |
| Jul 15, 2026 | 310,377 | 0.63% | +52% | 72,821 | 4.3 |
| Jun 30, 2026 | 204,812 | 0.42% | +100% | 69,545 | 3.0 |
| Jun 15, 2026 | 102,466 | 0.21% | -41% | 38,387 | 2.7 |
| May 29, 2026 | 172,764 | 0.35% | +13% | 31,383 | 5.5 |
| May 15, 2026 | 153,336 | 0.31% | -11% | 19,058 | 8.1 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Medicinova company events
Medicinova filed 6 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Sep 28, 2026.
- Sep 28, 2026AgreementMediciNova, Inc. amended its Lease, dated July 20, 2021, between the Company and the Irvine Company LLC pursuant to a First Amendment to the Lease, dated as of September 23, 2026, by and between the Company and Newport Gateway Office LLC. Pursuant to the Amendment, among other things, the parties… Filing
- Sep 2, 2026AgreementEnded an important agreement. Filing
- Aug 19, 2026LeadershipMediciNova, Inc. entered into new Executive Employment Agreements with each of Yuichi Iwaki, M.D., Ph.D., the Company’s President and Chief Executive Officer, and Kazuko Matsuda, M.D., Ph.D., MPH, the Company’s Chief Medical Officer (each of Dr. Iwaki and Dr. Matsuda, the “Executive”). Filing
- Jun 24, 2026VoteReported shareholder vote results. Filing
- Feb 20, 2026ResultsReleased financial results. Filing
- Dec 30, 2025AgreementMediciNova, Inc. entered into an equity distribution agreement with Lucid Capital Markets, LLC to sell shares of the Company’s common stock, par value $0.001 per share, from time to time through the Agent, acting as sales agent, having a maximum aggregate offering price of $50 million. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Medicinova financials
Famous investors that hold MNOV
2 of the 50 well-known investors we track reported holding MNOV in their latest 13F filing. The largest position is Jim Simons's, worth $376K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 224,595 | $376K | 0.0% | +9% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 35,455 | $59.4K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named MNOV in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 30, 2026 | Vanguard Capital Management | 13G | 7.2% |
| Oct 30, 2026 | Vanguard Capital Management | 13G | 7.2% |
Questions about Medicinova Inc (MNOV) stock
Are MNOV insiders buying or selling?
In the last 12 months, MNOV insiders reported no open-market purchases and 1 sale worth $1.7M. The latest trade was on Sep 25, 2026. See every trade.
What is the short interest in MNOV?
As of Oct 30, 2026, 285,184 MNOV shares were sold short, 0.6% of the shares outstanding, down 2.4% from the report before. At the average daily volume of 52,467 shares, buying them all back would take about 5.4 trading days (days to cover). See the history.
Which famous investors hold MNOV?
2 of the 50 well-known investors we track reported MNOV in their latest 13F filing, including Jim Simons, Ken Griffin. The largest position is worth $376K. See all holders.
Executive pay
Medicinova's chief executive was paid a total of $1.8M for the year ended Dec 31, 2025, up 25% from $1.4M the year before. In the last 12 months, Medicinova's executives and directors bought no stock on the open market and sold none.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.